Cargando…

P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM

Detalles Bibliográficos
Autores principales: Khan, E., Nourse, J., Tokalov, S., Khokhar, S., Arnold-Schild, D., Schott, L., Eder, L., Danckwardt, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429642/
http://dx.doi.org/10.1097/01.HS9.0000849612.93722.61
_version_ 1784779519462211584
author Khan, E.
Nourse, J.
Tokalov, S.
Khokhar, S.
Arnold-Schild, D.
Schott, L.
Eder, L.
Danckwardt, S.
author_facet Khan, E.
Nourse, J.
Tokalov, S.
Khokhar, S.
Arnold-Schild, D.
Schott, L.
Eder, L.
Danckwardt, S.
author_sort Khan, E.
collection PubMed
description
format Online
Article
Text
id pubmed-9429642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94296422022-08-31 P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM Khan, E. Nourse, J. Tokalov, S. Khokhar, S. Arnold-Schild, D. Schott, L. Eder, L. Danckwardt, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429642/ http://dx.doi.org/10.1097/01.HS9.0000849612.93722.61 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Khan, E.
Nourse, J.
Tokalov, S.
Khokhar, S.
Arnold-Schild, D.
Schott, L.
Eder, L.
Danckwardt, S.
P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title_full P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title_fullStr P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title_full_unstemmed P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title_short P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM
title_sort p1689: tissue-selective pharmacological targeting of tumor intrinsic prothrombin (f2) expression using an integrated genetic reporter system
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429642/
http://dx.doi.org/10.1097/01.HS9.0000849612.93722.61
work_keys_str_mv AT khane p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT noursej p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT tokalovs p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT khokhars p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT arnoldschildd p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT schottl p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT ederl p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem
AT danckwardts p1689tissueselectivepharmacologicaltargetingoftumorintrinsicprothrombinf2expressionusinganintegratedgeneticreportersystem